Prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: Guideline update and results of the Perugia consensus conference

Supportive Care in Cancer

Volumn 19, Issue SUPPL. 1, 2011, Pages

  Roila, Fausto ^a   Herrstedt, Jorn ^d   Gralla, Richard J ^b   Tonato, Maurizio ^c  

^a S MARIA HOSPITAL   (Italy)

^b DONALD AND BARBARA ZUCKER SCHOOL OF MEDICINE AT HOFSTRA NORTHWELL   (United States)

^c Regional Government of Umbria   (Italy)

^d NONE

Author keywords

ESMO antiemetic guidelines; MASCC antiemetic guidelines

Indexed keywords

ANTIEMETIC AGENT;

ANTICIPATORY NAUSEA AND VOMITING; CANCER CHEMOTHERAPY; CHEMOTHERAPY INDUCED NAUSEA AND VOMITING; CHILD CARE; CONFERENCE PAPER; DRUG CLASSIFICATION; HUMAN; ITALY; MEDICAL SOCIETY; NAUSEA AND VOMITING; ORGANIZATION AND MANAGEMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIOTHERAPY INDUCED NAUSEA AND VOMITING;

ANTIEMETICS; ANTINEOPLASTIC AGENTS; HUMANS; NAUSEA; RADIOTHERAPY; VOMITING;

EID: 79953316381     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-010-1044-1     Document Type: Conference Paper

References (2)

1. Roila F, Hesketh PJ, Herrstedt J et al (2006) Prevention of chemotherapy- and radiotherapy-induced emesis: results of the 2004 Perugia International Antiemetic Consensus Conference. Ann Oncol 17:20-28 (Pubitemid 43033835)
2. Herrstedt J, Roila F (2009) Chemotherapy-induced nausea and vomiting: ESMO clinical recommendations for prophylaxis. Ann Oncol 20(Suppl 4):156-158